Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06903897 · ClinicalTrials.gov registry record · NA

Social Needs Screening and Chronic Diseases Study (WE CARE)

A NA study of Depression and Hypertension, sponsored by University of Massachusetts, Worcester.

Recruiting
Registry status
NA
Development phase
68,000
Enrollment target
3
Study locations

NCT06903897: Recruiting NA study of Depression and Hypertension, sponsored by University of Massachusetts, Worcester.

NCT06903897 is a NA study of Depression and Hypertension that is actively recruiting participants, run by University of Massachusetts, Worcester. The registered enrollment target is 68,000 participants, above the 686-participant average among 679 other Depression trials with a reported enrollment target (9813% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06903897, a NA study of Depression and Hypertension, is actively recruiting participants, sponsored by University of Massachusetts, Worcester.

RECRUITING
Registry status
NA
Development phase
68,000 participants
Enrollment target
3
Study locations

Study Summary

The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertension, diabetes, depression, hyperlipidemia, and asthma through clinical measures. The main question it aims to answer is: Does the WE CARE SDOH screening and referral intervention applying an antiracism lens informed implementation strategies have the potential to reduce racial/ethnic health inequities in chronic diseases for minoritized patients?

Primary Outcome

Systolic and diastolic blood pressure measurements collected at all routine and follow-up visits for adults.

Interventions

  • OTHER WE CARE SDOH System
  • OTHER Standard Pediatric Care

Study Locations (3)

Massachusetts

  • (Benedict) UMass Memorial Medical Center - Adult Primary Care - Worcester
  • UMass Memorial Medical Center - Hahnemann Campus - Worcester
  • Family Health Center of Worcester - Worcester

Trial Details

FieldValue
Enrollment Target 68,000 participants
Start Date 2025-10-08
Est. Completion 2028-09-30
Phase NA

What NCT06903897 shows while recruiting

NCT06903897 is an interventional study that assigns participants to a tested intervention. Its 68,000 participants enrollment target places it among the larger protocols in the corpus, above the 686-participant average among 679 other Depression trials with a reported enrollment target (9813% higher).

The record links to 5 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which WE CARE SDOH System is the first listed.

NCT06903897 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06903897 about?

NCT06903897 is a clinical study titled "Social Needs Screening and Chronic Diseases Study (WE CARE)". The goal of this clinical trial is to learn if the implementation of the WE CARE social determinants of health (SDOH) screening and referral intervention with an antiracist lens in primary care settings can lead to a meaningful decrease in chronic disease by monitoring conditions such as hypertensio...

What is the current status of trial NCT06903897?

This trial is currently recruiting. It is a NA study. The enrollment target is 68,000 participants. The study started on 2025-10-08. Estimated completion is 2028-09-30.

What conditions does trial NCT06903897 study?

This clinical trial studies the following conditions: Depression, Hypertension, Diabetes, Hyperlipidemias, Pediatric Asthma.

What interventions are being tested in trial NCT06903897?

The interventions under investigation include: WE CARE SDOH System (OTHER), Standard Pediatric Care (OTHER).

Who is sponsoring clinical trial NCT06903897?

This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06903897 being conducted?

This trial has 3 study locations across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06903897's enrollment target sits among peer trials

68,000 2nd of 679 the highest of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00009633 · 68,000 participants

    Follow-up Visit of High Risk Infants

  • NCT04473833 · 65,000 participants · NA

    Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer

  • NCT05128006 · 63,200 participants

    Direct-to-patient Teledermatology and Computer-assisted Diagnosis

  • NCT06003192 · 63,000 participants · NA

    Screen Smart: Using Digital Health to Improve HIV Screening and Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06903897, the US trial registry maintained by the National Library of Medicine. NCT06903897 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.